What does a peripheral smear with 98% neutrophils indicate and how should I evaluate and manage the patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peripheral Smear with 98% Neutrophils: Evaluation and Management

Immediate Clinical Assessment

A peripheral smear showing 98% neutrophils represents a marked neutrophilia that demands urgent evaluation for serious bacterial infection, leukemoid reaction, or hematologic malignancy. This extreme neutrophil predominance (>90%) carries a likelihood ratio of 7.5 for bacterial infection and warrants immediate clinical correlation. 1

Critical First Steps

  • Check temperature immediately: A single oral temperature ≥38.3°C or sustained ≥38.0°C for ≥1 hour defines fever and mandates empiric broad-spectrum antibiotics within 2 hours if the absolute neutrophil count (ANC) is <500 cells/µL. 2

  • Calculate the absolute neutrophil count (ANC): Multiply the total WBC by 0.98 to determine if this represents neutrophilia (ANC >7.5 × 10⁹/L) or a relative neutrophilia with normal/low total WBC. 2

  • Assess for systemic infection signs: Look specifically for hemodynamic instability (hypotension, tachycardia), altered mental status (especially in elderly), respiratory distress, abdominal pain/peritoneal signs, or skin/soft tissue infection. 1

Diagnostic Workup Based on Clinical Context

High-Priority Infectious Etiologies

  • Obtain blood cultures from two separate sites before antibiotics if fever or sepsis is suspected, along with urinalysis/urine culture if urinary symptoms are present. 2

  • In cirrhotic patients with ascites: Perform diagnostic paracentesis immediately—spontaneous bacterial peritonitis is diagnosed when ascitic fluid neutrophils exceed 250 cells/mm³ and requires urgent antibiotics regardless of culture results. 1

  • Evaluate for tick-borne rickettsial diseases if there is recent tick exposure with headache, fever, or confusion. 1

  • Consider chest imaging if respiratory symptoms, hypoxemia, or tachypnea are present. 1

Distinguishing Benign from Malignant Leukocytosis

  • Examine the peripheral smear morphology carefully: Look for dysplastic features, immature myeloid precursors (blasts, promyelocytes, myelocytes), basophilia, eosinophilia, or a monomorphic versus pleomorphic appearance. 3

  • Leukemoid reaction (benign) typically shows:

    • Activated neutrophil changes (toxic granulation, Döhle bodies, vacuolation)
    • Left shift with bands but <10% immature precursors
    • Associated with infection (70% of cases), malignancy (7.5%), or bleeding (6.5%)
    • Neutrophil vacuolation is more common in infection (34%) but not specific 4
  • Myeloid malignancy (chronic myeloid leukemia, myeloproliferative neoplasms) shows:

    • Dysplastic neutrophils
    • ≥10% immature myeloid precursors (blasts, promyelocytes, myelocytes)
    • Basophilia or eosinophilia
    • Requires bone marrow examination with cytogenetics and molecular studies (BCR-ABL1, JAK2) 3

Management Algorithm

If Febrile or Septic (Medical Emergency)

  • Start IV antipseudomonal β-lactam within 2 hours: Cefepime 2g IV every 8 hours is preferred; alternatives include meropenem, imipenem, or piperacillin-tazobactam. 2

  • Add vancomycin only if: Suspected catheter-related infection, hemodynamic instability, known MRSA colonization, skin/soft tissue infection, or severe mucositis. 2

  • Continue antibiotics until: ANC >500 cells/µL for ≥2 consecutive days AND afebrile for ≥48 hours. 2

If Afebrile with Suspected Infection

  • Total WBC ≥14,000 cells/mm³ OR left shift (≥16% bands or absolute band count ≥1,500 cells/mm³): Warrants careful assessment for occult bacterial infection even without fever. 1

  • Obtain site-specific cultures as indicated by symptoms (respiratory, urinary, gastrointestinal, skin). 1

  • Do not start empiric antibiotics based solely on neutrophilia without fever or clinical signs of infection. 5

If No Infection Suspected

  • Review medication list: Corticosteroids, G-CSF, lithium, beta-agonists, and epinephrine can cause neutrophilia. 1

  • Assess for physiologic stress: Recent surgery, trauma, burns, myocardial infarction, or intense exercise can produce reactive neutrophilia. 5

  • Consider inflammatory conditions: Vasculitis, inflammatory bowel disease, or other autoimmune disorders. 5

  • If persistent neutrophilia (>2 weeks) without clear cause: Obtain bone marrow examination with cytogenetics and molecular studies to exclude myeloproliferative neoplasm. 3

Prognostic Considerations

  • Leukemoid reaction (WBC ≥25,000/µL with ≥80% mature neutrophils) carries a 29% in-hospital mortality rate, with higher peak WBC, increasing age, duration >1 day, and lack of associated invasive procedures predicting worse outcomes. 6

  • In polycythemia vera patients: Persistent neutrophilic leukocytosis ≥13 × 10⁹/L at or around progression to post-polycythemic myelofibrosis is associated with shorter overall survival and more aggressive disease. 7

Critical Pitfalls to Avoid

  • Do not delay empiric antibiotics beyond 2 hours in febrile patients while awaiting culture results or smear interpretation. 2

  • Do not ignore 98% neutrophils when total WBC is normal—left shift can occur with normal WBC and still indicate serious bacterial infection. 1

  • Do not assume infection is absent based solely on lack of fever; elderly or immunocompromised patients may present with altered mental status or hemodynamic instability without fever. 1

  • Do not overlook cirrhosis with ascites—any neutrophilia warrants diagnostic paracentesis to rule out spontaneous bacterial peritonitis. 1

  • Do not miss hematologic malignancy—if smear shows dysplasia, basophilia, or ≥10% immature precursors, proceed directly to bone marrow examination. 3

References

Guideline

Neutrophilia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Neutropenia Management and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Malignant or benign leukocytosis.

Hematology. American Society of Hematology. Education Program, 2012

Guideline

Neutrophil Count Interpretation and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prognostic significance of marked leukocytosis in hospitalized patients.

Journal of general internal medicine, 1991

Research

Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.